Gestational Hypertension & Pre-eclampsia: Recognition, Magnesium Toxicity, Delivery

Gestational Hypertension & Pre-eclampsia: Recognition, Magnesium Toxicity, Delivery

A high-density, practical guide for nurses, midwives, and medical professionals

What Is This?

Gestational hypertension (GH) and pre-eclampsia are pregnancy-specific hypertensive disorders that threaten maternal and fetal health. GH is new-onset hypertension (?140/90 mmHg) after 20 weeks gestation without proteinuria. Pre-eclampsia adds end-organ damage (e.g., proteinuria, renal/liver dysfunction, neurological symptoms) and can progress to eclampsia (seizures) or HELLP syndrome (hemolysis, elevated liver enzymes, low platelets).

Why it matters today: - Affects 5–8% of pregnancies worldwide. - Leading cause of maternal and perinatal morbidity/mortality. - Early recognition and management prevent seizures, stroke, placental abruption, and fetal growth restriction.

Why It Matters

Real-World Impact

• Maternal risks: Seizures, pulmonary edema, renal failure, placental abruption, disseminated intravascular coagulation (DIC), death.
• Fetal risks: Preterm birth, intrauterine growth restriction (IUGR), stillbirth, neonatal respiratory distress syndrome (RDS).
• Healthcare burden: Increased NICU admissions, longer hospital stays, and higher costs.

Problem It Solves

• Prevents progression from mild hypertension to life-threatening complications.
• Guides timely delivery to balance maternal safety and fetal maturity.
• Standardizes magnesium sulfate (MgSO?) use to prevent seizures while avoiding toxicity.

Core Concepts

1. Diagnostic Criteria

2. Pathophysiology

• Placental dysfunction-endothelial damage-vasoconstriction + increased vascular permeability.
• Key mediators: Soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PlGF), endothelin-1.
• Result: Reduced organ perfusion (brain, liver, kidneys, placenta).

3. Magnesium Sulfate (MgSO?) for Seizure Prophylaxis

• Mechanism: Blocks NMDA receptors, reduces neuronal excitability, and causes vasodilation.
• Dosing:
• Loading dose: 4–6 g IV over 15–20 minutes.
• Maintenance: 1–2 g/h IV infusion.
• Therapeutic range: 4–7 mg/dL (1.7–2.9 mmol/L).

4. Delivery Timing

• Term (?37 weeks): Deliver immediately if pre-eclampsia (with or without severe features).
• Preterm (<37 weeks):
• Without severe features: Expectant management (close monitoring, corticosteroids for fetal lung maturity).
• With severe features: Deliver within 24–48 hours (regardless of gestational age).

How It Works: Clinical Workflow

1. Recognition & Diagnosis

• Screen at every prenatal visit:
• Blood pressure (use correct cuff size, seated position, 5-minute rest).
• Symptoms: Headache, visual disturbances, epigastric/RUQ pain, sudden edema.
• Confirm pre-eclampsia:
• Urine dipstick (if ?1+ protein, send for 24-hour urine or protein:creatinine ratio).
• Labs: CBC (platelets), LFTs (AST/ALT), creatinine, LDH (for HELLP).
• Fetal assessment: Non-stress test (NST), biophysical profile (BPP), umbilical artery Doppler.

2. Risk Stratification

3. Magnesium Sulfate Administration

• Indications:
• Severe pre-eclampsia (seizure prophylaxis).
• Eclampsia (seizure treatment).
• Contraindications:
• Myasthenia gravis (risk of respiratory depression).
• Severe renal impairment (risk of toxicity).
• Monitoring:
• Patellar reflexes (loss = early toxicity).
• Respiratory rate (<12/min = toxicity).
• Urine output (<30 mL/h = risk of accumulation).
• Serum Mg²? levels (if renal dysfunction or signs of toxicity).

4. Delivery Planning

• Mode of delivery:
• Vaginal preferred if stable and favorable cervix.
• Cesarean section if:
  • Severe fetal distress.
  • Uncontrolled BP despite antihypertensives.
  • Eclampsia or HELLP syndrome.
• Anesthesia considerations:
• Avoid general anesthesia (risk of hypertensive crisis).
• Epidural preferred (if platelets >70k).

Hands-On: Step-by-Step Management

Prerequisites

• Knowledge: Hypertension in pregnancy, MgSO? pharmacology, fetal monitoring.
• Equipment:
• BP cuff, IV pump, MgSO? infusion, calcium gluconate (antidote).
• Fetal monitor, lab access (CBC, LFTs, creatinine).

Step 1: Assess & Diagnose

1. Measure BP (confirm with manual cuff if elevated).
2. Ask: "Do you have headaches, vision changes, or abdominal pain?"
3. Check urine dipstick (if ?1+, send for protein:creatinine ratio).
4. Order labs: CBC, LFTs, creatinine, LDH.
5. Perform NST and BPP.

Step 2: Initiate MgSO? for Severe Pre-eclampsia

1. Administer loading dose: 4–6 g MgSO? IV over 15–20 min.
2. Start maintenance: 2 g/h IV infusion.
3. Monitor:
   - Patellar reflexes (q1h).
   - Respiratory rate (q1h).
   - Urine output (q1h, report if <30 mL/h).
4. Check serum Mg²? at 4–6 hours (target: 4–7 mg/dL).

Step 3: Control Blood Pressure

• First-line antihypertensives:
• Labetalol (20 mg IV, then 40–80 mg q10min, max 300 mg).
• Hydralazine (5–10 mg IV q20min, max 20 mg).
• Nifedipine (10–20 mg PO q30min, max 50 mg).
• Goal: BP <160/110 mmHg (avoid rapid drops to maintain placental perfusion).

Step 4: Decide on Delivery

1. If ?37 weeks: Deliver within 24–48 hours.
2. If <34 weeks and stable: Administer corticosteroids (betamethasone 12 mg IM q24h x2), monitor closely.
3. If <34 weeks and severe: Deliver within 24–48 hours (balance risks of prematurity vs. maternal/fetal deterioration).

Expected Outcome

• Maternal: BP controlled, no seizures, stable labs.
• Fetal: Reactive NST, normal BPP, no signs of distress.
• Delivery: Safe vaginal or cesarean birth with minimal complications.

Common Pitfalls & Mistakes

1. Misdiagnosing Pre-eclampsia

• Mistake: Assuming hypertension alone = pre-eclampsia.
• Fix: Confirm proteinuria or end-organ damage (e.g., platelets <100k, AST >70 U/L).

2. Overlooking MgSO? Toxicity

• Mistake: Not monitoring reflexes, respiratory rate, or urine output.
• Fix:
• Stop MgSO? if:
  • Patellar reflexes absent.
  • Respiratory rate <12/min.
  • Urine output <30 mL/h.
• Administer calcium gluconate (1 g IV over 3 min) for toxicity.

3. Delaying Delivery in Severe Cases

• Mistake: Waiting for "fetal lung maturity" in severe pre-eclampsia.
• Fix: Deliver within 24–48 hours if severe features (regardless of gestational age).

4. Using ACE Inhibitors or ARBs

• Mistake: Prescribing lisinopril or losartan for hypertension.
• Fix: Contraindicated in pregnancy (fetal renal toxicity, oligohydramnios). Use labetalol, nifedipine, or methyldopa instead.

5. Ignoring Postpartum Risks

• Mistake: Discharging a patient without postpartum BP monitoring.
• Fix: Monitor BP daily for 72 hours, then at 3–5 days and 7–10 days postpartum (eclampsia can occur up to 6 weeks postpartum).

Best Practices

1. Early Recognition

• Screen all pregnant patients for hypertension at every visit.
• Teach patients warning signs: Headache, vision changes, RUQ pain, sudden swelling.

2. MgSO? Safety

• Always have calcium gluconate at bedside.
• Use a dedicated IV line (MgSO? is incompatible with many drugs).
• Monitor urine output (oliguria increases toxicity risk).

3. Antihypertensive Selection

4. Delivery Timing

• Term (?37 weeks): Deliver within 24–48 hours of diagnosis.
• Preterm (<37 weeks):
• Without severe features: Expectant management + corticosteroids.
• With severe features: Deliver within 24–48 hours (balance prematurity vs. maternal/fetal risk).

5. Postpartum Care

• Monitor BP for 72 hours (highest risk of eclampsia in first 48 hours).
• Continue MgSO? for 24 hours postpartum if severe pre-eclampsia.
• Educate on long-term risks: Increased lifetime risk of cardiovascular disease.

Tools & Frameworks

1. Diagnostic Tools

• 24-hour urine protein (gold standard for proteinuria).
• Protein:creatinine ratio (faster alternative to 24-hour urine).
• sFlt-1/PlGF ratio (emerging biomarker for pre-eclampsia risk).

2. Monitoring Equipment

• Automated BP cuffs (avoid manual errors).
• Fetal monitors (NST, BPP, Doppler ultrasound).
• IV pumps (for precise MgSO? dosing).

3. Clinical Guidelines

• ACOG (American College of Obstetricians and Gynecologists): Hypertension in Pregnancy
• NICE (UK): Hypertension in Pregnancy
• WHO: Recommendations for Prevention and Treatment of Pre-eclampsia

Real-World Use Cases

1. Emergency Department: New-Onset Seizures in Pregnancy

• Scenario: A 32-year-old at 36 weeks presents with tonic-clonic seizures.
• Actions:
• Stabilize: Airway, oxygen, left lateral position.
• Administer MgSO?: 4–6 g IV loading dose, then 2 g/h infusion.
• Control BP: Labetalol 20 mg IV.
• Deliver: Emergency cesarean section after stabilization.

2. Labor & Delivery: Severe Pre-eclampsia at 34 Weeks

• Scenario: A 28-year-old with BP 180/110, platelets 80k, AST 120 U/L.
• Actions:
• Hospitalize: Start MgSO?, monitor reflexes/respiratory rate.
• Administer corticosteroids: Betamethasone 12 mg IM x2.
• Deliver within 24–48 hours: Vaginal induction if favorable cervix, otherwise cesarean.

3. Postpartum Unit: Hypertension After Delivery

• Scenario: A 35-year-old 2 days postpartum with BP 160/100, headache, blurred vision.
• Actions:
• Rule out eclampsia: Check reflexes, MgSO? if needed.
• Control BP: Nifedipine 10 mg PO.
• Monitor for 72 hours: Discharge with BP log and follow-up in 3–5 days.

Check Your Understanding (MCQs)

Question 1

A 26-year-old at 32 weeks gestation presents with BP 150/95, 2+ proteinuria, and normal labs. What is the most appropriate next step?

A. Administer MgSO? immediately. B. Start labetalol 200 mg PO BID. C. Perform a 24-hour urine protein collection. D. Deliver via cesarean section within 24 hours.

Correct Answer: C Explanation: This patient has mild pre-eclampsia (BP <160/110, no severe features). The next step is to confirm proteinuria (24-hour urine or protein:creatinine ratio) before deciding on management. Why the distractors are tempting: - A: MgSO? is only for severe pre-eclampsia or eclampsia. - B: Antihypertensives are not indicated unless BP is ?160/110. - D: Delivery is not indicated at 32 weeks without severe features.

Question 2

A patient on MgSO? infusion develops absent patellar reflexes and a respiratory rate of 10/min. What is the first action?

A. Increase the MgSO? infusion rate. B. Administer calcium gluconate 1 g IV. C. Check serum magnesium level. D. Intubate the patient.

Correct Answer: B Explanation: Absent reflexes + respiratory depression = Mg